Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment.
ACS Medicinal Chemistry Letters November 14, 2024 DOI: 10.1021/acsmedchemlett.4c00490 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Patent review Peer reviewed |
|---|---|
| Interventions | 5-MeO-DMT DMT |
| Topics | Psychedelic-assisted therapy 5-MeO-DMT DMT |
| Keywords | Alternative medicine Depression treatment Therapeutic compounds Mental health treatment |
| Citations | 3 |
| Key findings | Recent patents describe innovative strategies for using 5-MeO-DMT and DMT to treat severe psychiatric conditions, including combination with mood preparation agents, prodrug formulations, and tailored therapies for specific populations. |
Abstract
Recent advancements in the therapeutic use of psychedelic compounds, particularly 5-MeO-DMT and DMT, have demonstrated significant potential in treating various mental health disorders. This Patent Highlight evaluates findings from multiple recent patents that explore novel applications of these compounds, including their use in severe psychiatric conditions such as depression, anxiety, and trauma-related disorders. The patents reveal innovative strategies, such as combining 5-MeO-DMT with mood preparation agents to enhance safety and efficacy, developing DMT prodrugs for improved pharmacokinetics, and targeting specific populations like breastfeeding mothers with tailored psychedelic therapies. These advancements offer new hope for patients with treatment-resistant mental disorders, highlighting the evolving role of psychedelics in mental health care.
Comparable studies
Other narrative reviews on 5-MeO-DMT, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Neuropharmacology of N,N-dimethyltryptamine | 2016 | Review | |
| N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function Humans and animals (general) | 2018 | Review | |
| Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Humans (pharmacokinetics) | 2010 | Review | |
| Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT) | 2018 | Review | |
| A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. | 2013 | Review |
Citations in the library
Cited by 4
- Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants Science Advances April 1, 2026
- Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta-analysis Journal of Psychopharmacology April 12, 2026
- Fabricated Ancestrality: The Sonoran Desert Toad, Psychedelic Globalization, and the Ecological Politics of 5-MeO-DMT Psychedelics March 1, 2026
- Higher signal diversity, network dysregulation, and increased well-being under DMT administration: An EEG study. Brain Research September 7, 2026
Cites 6
- Adverse Events in Studies of Classic Psychedelics JAMA Psychiatry September 4, 2024
- Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile Biological Psychiatry: Cognitive Neuroscience and Neuroimaging February 1, 2024
- Drug–drug interactions involving classic psychedelics: A systematic review Journal of Psychopharmacology November 20, 2023
- The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action Addiction Biology April 1, 2024
- Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials. Frontiers in Psychiatry 2024
and 1 more in the library